Patent · US Active

Peptide-cytotoxic conjugates

US8236762B2 · kind B2 · utility

4Cited by
0References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 17, 2007
Grant dateAug 7, 2012
Priority date
Expiry dateJan 19, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features targeted cytotoxic compounds and methods relating to their therapeutic use for the treatment of neoplasia and other conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.